Avenzoar Pharmaceuticals, Inc.

Pharmaceutical company · Los Angeles, California, United States

Avenzoar Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Los Angeles, California, United States. Its earliest recorded incorporation is in 2015. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $212,201 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $899,748 sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Avenzoar Pharmaceuticals at a glance

Typepharmaceutical company
HeadquartersLos Angeles, California, United States
Earliest incorporation on record2015
Employees (self-reported, 2019)3
SEC CIK1792612

What does Avenzoar Pharmaceuticals do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $212,201 in total (2019). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $899,748 sold (2023).

Frequently asked questions about Avenzoar Pharmaceuticals

Where is Avenzoar Pharmaceuticals headquartered?

Avenzoar Pharmaceuticals, Inc. is headquartered in Los Angeles, California, United States.

What does Avenzoar Pharmaceuticals do?

Avenzoar Pharmaceuticals, Inc. is a pharmaceutical company.

When was Avenzoar Pharmaceuticals founded?

The earliest incorporation on record for Avenzoar Pharmaceuticals, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences